BioAxone BioSciences Inc. is focused on the development of innovative drugs to restore neurological function and improve quality of life for patients with spinal cord injury and neurotrauma.

Our lead product, Cethrin™ is a proprietary biological drug, and our clinical Phase 2b program is paving the way as the most advanced treatment for spinal cord injury.

Phase II clinical results show enormous promise of Cethrin to promote meaningful and substantial recovery and to safely advance the road to repair.

Cethrin is a Phase 2 drug that is available for development partnership.